Loading...
Loading...
Browse all stories on DeepNewz
VisitCommure Acquires Augmedix (AUGX) for $139 Million at $2.35/Share
Jul 19, 2024, 12:55 PM
Commure, Inc. has announced its acquisition of Augmedix, Inc. (NASDAQ: AUGX) for $2.35 per share in cash, valuing the deal at $139 million. The acquisition represents a 155.4% premium over Augmedix's previous share price. Augmedix, known for its AI-powered medical documentation solutions, aims to enhance its ambient documentation capabilities and bring more innovation to clinicians and health systems through this merger. This acquisition follows Commure's recent merger with Athelas into a $6 billion enterprise in late 2023. The deal is expected to close by July 25, with a tender offer expiring on Aug 15.
View original story
Below $1 Billion • 25%
$1 Billion to $2 Billion • 25%
$2 Billion to $3 Billion • 25%
Above $3 Billion • 25%
Below $3 billion • 25%
$3 billion to $5 billion • 25%
$5 billion to $7 billion • 25%
Above $7 billion • 25%
Less than $100 million • 25%
$100 million to $500 million • 25%
$500 million to $1 billion • 25%
Over $1 billion • 25%
Above $600 billion • 25%
$550 billion to $600 billion • 25%
$500 billion to $550 billion • 25%
Below $500 billion • 25%
Less than $1 billion • 25%
$1 billion to $5 billion • 25%
$5 billion to $10 billion • 25%
More than $10 billion • 25%
Below $15 billion • 25%
$15-$19.99 billion • 25%
$20-$24.99 billion • 25%
$25 billion or above • 25%
Less than $10 billion • 25%
$10 billion - $15 billion • 25%
$15 billion - $20 billion • 25%
More than $20 billion • 25%
Under $1 billion • 25%
$1 billion to $5 billion • 25%
$5 billion to $10 billion • 25%
Over $10 billion • 25%
1st • 25%
2nd • 25%
3rd • 25%
4th or lower • 25%
Above $1 billion • 25%
Between $750 million and $1 billion • 25%
Between $500 million and $750 million • 25%
Below $500 million • 25%
Under $8 billion • 25%
$8 billion to $10 billion • 25%
$10 billion to $12 billion • 25%
Over $12 billion • 25%
Below $1 billion • 25%
$1 billion to $2 billion • 25%
$2 billion to $3 billion • 25%
Above $3 billion • 25%
No • 50%
Yes • 50%
Pharmaceutical company • 25%
Healthcare company • 25%
Other • 25%
AI/Tech company • 25%